Preferred Label : Emapalumab;
Origin ID : C000644327;
UMLS CUI : C4740904;
ATC code(s)
- Currated CISMeF NLP mapping
- MeSH indexing information
- MeSH term(s) associated for indexing
- Record concept(s)
- Semantic type(s)
- UMLS correspondences (same concept)
- Validated automatic mappings to BTNT
https://www.ema.europa.eu/en/medicines/human/EPAR/gamifant
2021
false
false
false
Netherlands
French
English
treatment outcome
treatment outcome
treatment outcome
Emapalumab
Emapalumab
Emapalumab
antibodies, neutralizing
antibodies, neutralizing
antibodies, neutralizing
antibodies, monoclonal
antibodies, monoclonal
antibodies, monoclonal
syndication feed
syndication feed
syndication feed
summary of product characteristics
summary of product characteristics
summary of product characteristics
package leaflet
package leaflet
package leaflet
drug evaluation
drug evaluation
drug evaluation
child
child
child
adolescent
adolescent
adolescent
lymphohistiocytosis, hemophagocytic
lymphohistiocytosis, hemophagocytic
lymphohistiocytosis, hemophagocytic
familial hemophagocytic lymphocytosis
familial hemophagocytic lymphocytosis
familial hemophagocytic lymphocytosis
infusions, intravenous
infusions, intravenous
infusions, intravenous
orphan drug production
orphan drug production
orphan drug production
emapalumab
emapalumab
emapalumab
europe
europe
europe
Gamifant
Gamifant
Gamifant
Emapalumab
Emapalumab
Emapalumab
---
